292 related articles for article (PubMed ID: 27257145)
1. MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis.
Dinnes J; Bancos I; Ferrante di Ruffano L; Chortis V; Davenport C; Bayliss S; Sahdev A; Guest P; Fassnacht M; Deeks JJ; Arlt W
Eur J Endocrinol; 2016 Aug; 175(2):R51-64. PubMed ID: 27257145
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Imaging modalities for characterising focal pancreatic lesions.
Best LM; Rawji V; Pereira SP; Davidson BR; Gurusamy KS
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010213. PubMed ID: 28415140
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.
Stone WZ; Wymer DC; Canales BK
J Endourol; 2014 Jan; 28(1):104-11. PubMed ID: 23927734
[TBL] [Abstract][Full Text] [Related]
5. Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?
Tessonnier L; Sebag F; Palazzo FF; Colavolpe C; De Micco C; Mancini J; Conte-Devolx B; Henry JF; Mundler O; Taïeb D
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2018-25. PubMed ID: 18566816
[TBL] [Abstract][Full Text] [Related]
6. Incidental non-secreting adrenal masses in cancer patients: intra-individual comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging.
Gratz S; Kemke B; Kaiser W; Heinis J; Behr TM; Höffken H
J Int Med Res; 2010; 38(2):633-44. PubMed ID: 20515577
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of incidentally discovered adrenal masses with PET and PET/CT.
Wong KK; Arabi M; Bou-Assaly W; Marzola MC; Rubello D; Gross MD
Eur J Radiol; 2012 Mar; 81(3):441-50. PubMed ID: 21295930
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of
Kim SJ; Lee SW; Pak K; Kim IJ; Kim K
Br J Radiol; 2018 Jun; 91(1086):20170520. PubMed ID: 29327944
[TBL] [Abstract][Full Text] [Related]
9. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
10. Contemporary imaging of incidentally discovered adrenal masses.
Wale DJ; Wong KK; Viglianti BL; Rubello D; Gross MD
Biomed Pharmacother; 2017 Mar; 87():256-262. PubMed ID: 28063406
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors.
Schaafsma M; Berends AMA; Links TP; Brouwers AH; Kerstens MN
J Clin Endocrinol Metab; 2023 Aug; 108(9):2435-2445. PubMed ID: 36948598
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
14. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
15. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance.
Boland GW; Dwamena BA; Jagtiani Sangwaiya M; Goehler AG; Blake MA; Hahn PF; Scott JA; Kalra MK
Radiology; 2011 Apr; 259(1):117-26. PubMed ID: 21330566
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography versus magnetic resonance imaging versus bone scintigraphy for clinically suspected scaphoid fractures in patients with negative plain radiographs.
Mallee WH; Wang J; Poolman RW; Kloen P; Maas M; de Vet HC; Doornberg JN
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010023. PubMed ID: 26045406
[TBL] [Abstract][Full Text] [Related]
17. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses.
Song JH; Chaudhry FS; Mayo-Smith WW
AJR Am J Roentgenol; 2007 Nov; 189(5):1119-23. PubMed ID: 17954649
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
[TBL] [Abstract][Full Text] [Related]
20. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]